Johnson & Johnson’s Jennifer Taubert Named Among Fortune’s Most Powerful Women By Featured Partner October 20, 2022
Johnson & Johnson Shares Way It Supports Mental Health Care in Hispanic and Latino Communities By Featured Partner October 12, 2022
People on the Move: Pamela Fisher, New Chief Diversity and Inclusion Officer for Bristol-Myers Squibb By Brian Good November 22, 2021
DiversityInc 2021 Top 50 event: Leading in Challenging Times: A Panel Discussion By DiversityInc Staff May 6, 2021
Johnson & Johnson Statement on CDC Advisory Committee Meeting on Company COVID-19 Vaccine By Featured Partner April 19, 2021
Fauci Again Blames Institutional Racism for COVID-19’s Impact on Black People; Biden Nominates First-Ever Native American to Cabinet; and More By Brian Good December 18, 2020
Johnson & Johnson’s Re-Ignite Program Engages Professionals Returning to STEM Careers By DiversityInc Staff July 29, 2020
Johnson & Johnson Working to Develop Potential Vaccine for COVID-19 By Featured Partner March 1, 2020
‘I Have a Vision for Helping Advance Healthcare’: Meet 6 Leaders Working on Inspiring Innovations in 2020 By Featured Partner January 1, 2020
Johnson & Johnson Announces Commitment to Support Republic of Rwanda’s Preparedness Against Ebola Outbreak By Featured Partner December 8, 2019
J&J, Hershey, EY and Others Champion Career Advancement for People of Color in Supply Chain Roles By Featured Partner December 3, 2019
New Analysis from Landmark CREDENCE Study Shows the Efficacy and Safety Profiles of INVOKANA® (canagliflozin) are Consistent Across Various Levels of Kidney Function By Featured Partner November 27, 2019
Johnson & Johnson Releases Inaugural You Belong: Diversity & Inclusion Impact Review By Featured Partner October 22, 2019
Johnson & Johnson Commits $500 Million Investment Over Four Years to Help End the Epidemics of HIV and Tuberculosis By Featured Partner October 4, 2019
During Suicide Prevention Week, People of Color’s Mental Health Struggles Cannot be Forgotten By DiversityInc Staff September 10, 2019
Johnson & Johnson: XARELTO Helps Protect Pediatric Patients from Blood Clots in Late-Breaking Phase 3 EINSTEIN-Jr Study By Featured Partner July 12, 2019
Johnson & Johnson: New Evidence Highlights Need for Interventions to Improve Outcomes for Patients Wth Major Depressive Disorder and Suicide Ideation or Attempt By Featured Partner May 28, 2019
Johnson & Johnson, Bayer Execs Discuss Effective Sponsorship for People of Color and Women By Featured Partner May 9, 2019
Johnson & Johnson: Caring for Care Providers: An Innovative Way to Help Address the Growing Crisis of Doctor and Nurse Burnout By Featured Partner April 30, 2019
Johnson & Johnson: From Aha! Moment to FDA Approval: The Fascinating Story Behind a New Treatment for Bladder Cancer By Featured Partner April 19, 2019
